ReviewBiopolymers2025
Upcycling Eggshell Matrix for Sustainable Production of Glycosaminoglycans.
Review in Biopolymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glycosaminoglycans (GAGs) are biomolecules with applications in the pharmaceutical, cosmetic, and nutraceutical industries. However, traditional GAG sources, such as animal tissues and marine organisms, present imminent challenges, including structural heterogeneity, contamination risk, and geographical sourcing limitations. This review explores the potential of the eggshell matrix, an abundant yet underutilized by-product of the egg industry, as a sustainable and cost-effective alternative source of GAG production. This review examined the composition of the eggshell matrix, highlighting its rich content of hyaluronic acid, chondroitin sulfate, and other valuable GAGs, coupled with their extraction and purification techniques. The advantages of eggshell matrix-derived GAGs, including their consistent molecular properties, lower allergenicity, and alignment with circular economy principles, are also discussed. Additionally, this review highlights the industrial scalability of eggshell matrix valorization and its potential to mitigate environmental waste while meeting global GAG demand. The eggshell matrix shows promise for GAG production, with hyaluronic acid, chondroitin sulfate, and dermatan sulfate already identified, but more work is needed to improve extraction efficiency, broaden industrial uses, and ensure commercial success. This represents the broad areas of process optimization, technological integration, and comprehensive economic evaluation. By addressing current challenges and future research directions, this review underscores the transformative potential of eggshell matrix-derived GAGs for advancing sustainable biomaterial production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.